echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Lancet Child Health: Ear temperature 39.0 c as diagnostic criteria for reducing fever in children with chemotherapy neutrope%

    Lancet Child Health: Ear temperature 39.0 c as diagnostic criteria for reducing fever in children with chemotherapy neutrope%

    • Last Update: 2020-06-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Neutlyte cell-reduced fever is the most common complication of chemotherapy for cancer, and the temperature limit systos for fever is clinically differentHigher limits avoid unnecessary diagnosisRecently, the researchers compared the clinical safety differencebetween between the temperature limit of 39.0 degrees C and 38.5 degrees C in childrenstudies conducted in Switzerland, involving patients with any malignant tumor (1 to 18 years of age) who received marrow-inhibited chemotherapy that is expected to last 2 months or more, randomly received ear temperature and fever limits of 39.0 degrees C or 38.5 degrees C to diagnose neutrophil-reduced fever, confirmed patients are required to undergo emergency hospitalization, examination (including blood culture), necessary anti-fever drugs and empirical intravenous injection spree antibioticsThe main results of the study were neutrophil reduction fever rates and safety-related events (SRE) for each chemotherapy year269 patients, 48% of the patients were assigned to the 39.0 C groupOf the 360 cases of neutrophil-reduced fever, 72 (20%) were sREs (0 deaths, 16 cases of intensive care, 22 cases of severe sepsis and 56 cases of bacteremia)In patients randomly divided into 39.0 degrees C fever group, 151 cases were diagnosed with neutrophil reduction of fever (1.64 times per year), of which 22 cases (15%) were accompanied by SRE (0.24 times per year)In the 38.5-degree C group, a total of 209 diagnoses (2.03 per year) were diagnosed, of which 50 (24%) were SRE (0.49 per year)The mixed Poisson regression rate (RR) of 39.0 degrees C and 38.5 degrees C for neutrophil reduction disease and SRE was 0.56, respectively, and the relative risk of neutroperacytic hypoglycemia fever was 0.83studies have concluded that it is safe for children undergoing chemotherapy for cancer to use ear temperature 39.0 degrees C as a diagnostic criterion for reducing fever in neutrophils
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.